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Purpose: The purpose of this retrospective chart review was to determine how primary molars 
needing vital pulp therapy have been treated in the past four years at Virginia Commonwealth 
University (VCU) and to determine which treatments: indirect pulp therapy (IPT), formocresol 
pulpotomy, and ferric sulfate pulpotomy have been successful. Methods: AxiUm records that 
contained the procedure codes D3120 (Pulp Cap – Indirect) or D3220 (Therapeutic Pulpotomy) 
were totaled by year. Visit records were queried again to identify treatment failures i.e. 
extractions or pulpectomy. Results: In 2010, 52% of vital pulp therapies were ferric sulfate 
pulpotomies and in 2014 over 90% were indirect pulp therapy. Indirect pulp therapy had a 96.2% 
success rate, formocresol pulpotomy had a 65.8% success rate and ferric sulfate had a 62.9% 
success rate at three years (P<.0001). Conclusions: Indirect pulp therapy is a successful 
treatment option for the primary tooth with deep caries approaching the pulp. 
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Introduction 
 
 There are three techniques to vital pulp therapy that have been recently taught and 
utilized at VCU pediatric dentistry: 1) the formocresol pulpotomy 2) the ferric sulfate pulpotomy 
3) indirect pulp therapy. With the advent of new research and a change in faculty, the hypothesis 
is that there has been a trend from the traditional formocresol pulpotomy, to the ferric sulfate 
pulpotomy, to now indirect pulp therapy. By examining the success and failure rates for each 
procedure, the VCU vital pulp therapy trend will either be justified or need modification. 
The formocresol pulpotomy was developed in 1932 by Sweet and is still the most 
common treatment for teeth with caries approaching the pulp. The goal of the pulpotomy is to 
maintain the radicular pulp and remove the coronal pulp in an effort to maintain the tooth in the 
arch.1 The current recommendation is to use a 1:5 dilution of Buckley’s formocresol (19% 
formaldehyde).2  By virtue of the formaldehyde and cresol moieties the solution has tissue 
fixative and antimicrobial properties that will fix and devitalize the irritated pulp.3 The Buckley’s 
full strength (19% formaldehyde, 35% cresol) is the formulation used at VCU. Formocresol 
studies show around a 92% short term (6-12 month) success and around a 70% long term (36-40 
month) success.4  Many residency programs (82%)5 teach the formocresol pulpotomy and the 
majority of practitioners still use it.6  At VCU it seems the formocresol pulpotomy was utilized 
more in the past, but currently more conservative therapies are favored.    
   The ferric sulfate pulpotomy was initially introduced to preserve the pulp by 
minimizing inflammation.7 In contact with blood, a ferric ion protein complex is formed and the 
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membrane of this complex seals the cut blood vessels mechanically, producing hemostasis. It 
was thought that controlling pulpal hemorrhage with ferric sulfate may prevent the problems 
previously encountered by blood clot formation with calcium hydroxide.7 Studies have shown 
varying degrees of clinical and radiographic success (74-100%),1 and some studies report 
internal root resorption and calcific metamorphosis.5  A 15.5 % ferric sulfate concentration is 
used at VCU.  
The mineral trioxide aggregate (MTA) pulpotomy has a very high success rate (96-
100%),8 but due to the high cost of MTA, it is not used at VCU or many other residency 
programs for primary tooth pulpotomies.5  In this study, the formocresol and ferric sulfate 
pulpotomies will be evaluated. Though chlorhexidine and Vitapex pulpotomies were completed, 
those treatments will not be included in the survival analysis. 
Indirect pulp therapy has become the front runner in vital pulp therapy at VCU. It is a 
procedure performed in a tooth with a deep carious lesion approximating the pulp but without 
signs or symptoms of pulp degeneration. The caries on the lateral walls is removed while the 
caries closest to the pulp is left in an effort to avoid pulp exposure.  It is then covered with a 
biocompatible material.9 At VCU the biocompatible liner used is Vitrebond, a resin modified 
glass ionomer. Indirect pulp therapy usually shows success rates of 90% or greater no matter the 
technique, medicament, or follow up time period.4   Indirect pulp therapy is becoming a more 
popular treatment option amongst practicing pediatric dentists, though the technique seems to be 
catching on at a slow pace.5,6,10    
Regardless of the technique, there are several goals of vital pulp therapy: 1) to preserve 
space for the underlying permanent tooth, 2) to eradicate potential infection, or 3) to maintain the 
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primary tooth if no permanent successor exists.1  The key to successful outcomes with any pulp 
therapy is accurate pulpal diagnosis. This can be particularly challenging with children, who are 
poor historians. Teeth diagnosed as having irreversible pulpitis may have: spontaneous 
throbbing, constant pain, advanced pulp degeneration, a percussion response, a radiolucency 
periapically or in the furcation, an abscess or fistula if the pulp is necrotic, internal or external 
root resorption, or mobility.11 According to AAPD guidelines, treatment options for the non-vital 
primary tooth are: pulpectomy or extraction.9 Teeth with irreversible pulpitis or a necrotic pulp 
were not considered in this study. 
   A history of provoked pain that is relieved by removal of the noxious stimuli is indicative 
of reversible pulpitis. These teeth are not painful to percussion and do not exhibit pathologic 
mobility or internal or external root resorption. Radiographs show decay close to the pulp and the 
absence of periapical or furcation radiolucencies. Teeth with reversible pulpitis have 
inflammation confined to the superficial layers of the coronal pulp and are good candidates for 
vital pulp therapies such as indirect pulp therapy and pulpotomies.11 Only teeth with reversible 
pulpitis were examined in this study 
The hypothesis is that VCU pediatric dentistry is doing less formocresol pulpotomies and 
more indirect pulp therapy. The study will determine whether that trend is justified or needs to be 
modified by examining success or failure rates of each of the three therapies. If the formocresol 
pulpotomy or ferric sulfate pulpotomy are more successful than hypothesized, then the 
curriculum will need to be adjusted. If indirect pulp therapy proves to be successful, then the 
trend is justified and perhaps more programs directors will use it clinically. (Dunston et al found 
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that only 30% of pediatric dentistry program directors recommended indirect pulp therapy when 
given the scenario of caries approaching the primary tooth pulp.) 6  
It is important that the most successful techniques are advocated in residency training. 
Practicing pediatric dentists utilize techniques learned in residency throughout their careers. If 
other treatment options prove to be more successful they should be taught and utilized.  
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Materials and Methods 
 
The subjects for this study were identified in the following steps 1) screening and 2) 
eligibility. 
The screening step was designed to all potential patients. An AxiUm (VCU’s electronic 
dental record system) query with the following criteria was executed: date range = 2010 through 
2014, treatment clinic = PEDO (6), and CDT procedure code = either D3120 (Pulp Cap – 
Indirect) or D3220 (Therapeutic Pulpotomy). This identified 3081 potential teeth. The second 
step excluded 503 patient records (983 teeth) who were not in the specified age range (age 2 to 
14) or did not have treatment completed on primary molars (#A, B, I, J, K, L, S, T) resulting in 
2,098 teeth. These 2,098 teeth were treated before June of 2014 and were included in analyses 
for the study. Procedures were completed either in the pediatric clinic under general anesthesia, 
oral sedation, nitrous oxide sedation with local anesthesia or in the operating room under general 
anesthesia. The treatment was performed by residents or VCU faculty. 
To identify which material was used for the pulpotomies, a complete list of cases was 
given to the primary author, who went through the AxiUm database, inspected the treatment 
notes, and identified whether ferric sulfate or formocresol pulpotomies or “other” medicament 
was used. If there was a discrepancy in what was charged out versus what was in the clinical 
notes, that tooth was excluded from the study. If the clinical note did not specify what 
medicament was used, that tooth was also excluded from the study. Twenty six teeth were 
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excluded for the aforementioned reasons. There were 1555 indirect pulp therapies completed, 
238 formocresol pulpotomies completed, 208 ferric sulfate pulptomies completed, and 71 
“other” pulpotomy medicaments used. All procedures were tallied by year and recorded as a 
percentage.   
A second AxiUm query used the patient chart number, treatment date, and tooth number 
to identify any subsequent treatment performed on that tooth and to identify the last patient visit 
to the VCU dental practices. Subsequent visit records were queried to identify any subsequent 
extractions of the tooth (CDT procedure code = D7140), or further nerve treatment: pulpectomy 
(CDT= D3221, or D3240). These were marked as a treatment failure. Treatment success/failures 
were tallied until June 14, 2014. A treatment success was indicated if there was no subsequent 
extraction or pulpectomy. The duration of a successful treatment was calculated by the number 
of days between the treatment and the last patient visit. The duration of an unsuccessful 
treatment was calculated by the number of days between the treatment and the extraction date, or 
additional treatment date.  
 A Kaplan-Meir survival analysis was used to compare if or when each treatment modality 
failed. Included in the survival analysis were ferric sulfate pulpotomies, formocresol 
pulpotomies, and indirect pulp therapy. “Other medicaments” were not included. In the survival 
analysis, treatment failures were uncensored and treatment successes were censored. Log rank 
test was used to determine if groups were significantly different. All analyses were performed 
using system analytical software (SAS) by the project biostatistician, Dr. Best. 
The purpose of this retrospective study is to identify how reversible pulpitis in the 
primary posterior tooth has been treated over the past four years at VCU pediatric dentistry and 
to determine what treatment modalities (indirect pulp therapy, formocresol pulpotomy, or ferric 
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sulfate pulpotomy) have been successful. This project was approved under exempt status from 
the Virginia Commonwealth University Institutional Review Board (VCU IRB #: 
HM20000596).
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Results 
 
 
 There are three major sections included in the results: A description of the patients and 
teeth, a description of the change in therapy from the ferric sulfate pulpotomy in 2010 to indirect 
pulp therapy in 2013-2014, and the success of the therapies (indirect pulp therapy, formocresol 
pulpotomy, and ferric sulfate pulpotomy) across time. 
 A total of 907 patients who were eligible for the study were treated between July 2010 
and May 2014. Of the study population, 55% were male, 48% were African-American, and 6.7% 
were Caucasian (Table 1). There were a total of 2,072 teeth treated with vital pulp therapy, with 
approximately equal numbers of each of the eight primary molars: A, B, I, J, K, L, S, T. Tooth K 
was treated most often at 15.1%, with its antimere, tooth T at 14.2% (Table 2). Age range was 2-
14 years of age with an average of age of 6.67 years (See Figure 1). Patients were from a low 
socioeconomic status and were considered high caries risk due to their young age and amount of 
dental caries. Patients were either treated in one of the VCU hospitals in the operating room 
under general anesthesia or in the pediatric clinic at VCU under general anesthesia, oral sedation, 
nitrous oxide sedation, or with no sedation and only local anesthesia. Treatment was completed 
by mostly faculty and pediatric dental residents, and less than 1% of procedures were completed 
by dental students.  
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 Table 3 shows the number of patients that received vital pulp therapy treatment each year 
from July 2010 to May 2014 with a total of 907 patients. In 2013, 273 patients were treated with 
vital pulp therapy.   
 Table 4 shows which pulp therapy procedures have been completed in 2010, 2011, 2012, 
2013, and 2014. The “other” column in Table 4 includes cases where chlorhexidine or Vitapex or 
a combination of ferric sulfate and chlorhexidine was used. In 2010, 52% of vital pulp therapy 
procedures were ferric sulfate pulpotomies, while 38% were indirect pulp therapy, and only 5% 
were formocresol pulptomies. In 2011, 54% of vital pulp therapy were indirect pulp therapies, 
while 28% were formocresol pulpotomies and 15% were ferric sulfate pulpotomies. In 2012, 
83% of vital pulp procedures were indirect pulp therapies, while 14% were formocresol 
pulpotomies, and about 4% of teeth were either treated with ferric sulfate or another medicament. 
In 2013 and 2014 over 90% of teeth that needed vital pulp therapy received indirect pulp 
therapies. A total of 1555 indirect pulp therapy, 238 formocresol pulpotomies, and 208 ferric 
sulfate pulpotomy procedures have been completed and 71 “other” medicaments have been used. 
Included in the “other medicaments” were 4 Vitapex pulpotomies and 10 chlorhexidine 
pulpotomies. In 2010 the predominant treatment was therapeutic pulpotomy using ferric sulfate 
but by 2014, it was a rarity. This change was statistically significant (chi-square P < .0001). This 
trend is depicted graphically in Figure 2. 
The primary aim of the study was to determine the success rate of the three main 
therapies: indirect pulp therapy, therapeutic pulpotomy using formocresol, and therapeutic 
pulpotomy using ferric sulfate. The 71 “other” treatments were excluded from the 2072 vital 
pulp therapy teeth for the survival analysis, therefore N=2001. In total, 6/1555 (0.38%) indirect 
pulp therapy failed, 9/238 (3.7%) formocresol pulpotomies failed, and 26/208 (12.5%) ferric 
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sulfate pulpotomies failed between May 2010 and June 2014. Not included in the analysis were 
2/10 (20%) chlorhexidine pulpotomy failures and 0/4 Vitapex pulpotomy failures. Failure rates 
for indirect pulp therapy, formocresol pulpotomy, and ferric sulfate pulpotomy appear to be low 
and similar when time is not considered, however Kaplan-Meier survival analysis across time 
clearly showed that the three treatments did not have an equal success (P < .0001, Table 5 and 
Figure 3).  
 Table 5 shows that the 281 indirect pulp therapies still at risk after one year had only seen 
3 prior failures, for a 99.3% success rate. This rate appeared similar to the 98.9% one year 
survival proportion for the 54 formocresol pulpotomies cases and this seemed higher than the 
87.2% success rates of the 70 ferric sulfate pulpotomies. By 2 years, the success rate of the 
therapeutic pulpotomies (85.9 % for formocresol and 75.6 % ferric sulfate) was substantially 
lower than the 98.8% success rate of indirect pulp therapy. And, by 3 years, the 96.2% success 
rate for indirect pulp therapy was clearly higher than the 63–66% success rate for therapeutic 
pulpotomies.  
 Figure 4 shows that there was no significant difference in success rates between first and 
second molars for indirect pulp therapy or pulpotomy (P > 0.6, Figure 4). There were 
approximately an equal number of failures for first versus second primary molars. 
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Discussion 
 
 
 The purpose of this retrospective study is to identify how reversible pulpitis in the 
primary posterior tooth has been treated over the past four years at VCU pediatric dentistry and 
to determine what treatment modalities (indirect pulp therapy, formocresol pulpotomy, or ferric 
sulfate pulpotomy) have been successful. In 2010, 52% of vital pulp therapy procedures were 
ferric sulfate, while in 2014 only 2% of vital pulp procedures were ferric sulfate. In 2010, 38% of 
vital pulp therapy procedures were indirect pulp therapy while in 2014 about 91% of vital pulp 
therapies were indirect pulp therapy. The formocresol pulpotomy saw most use in 2011 with 
28% of vital pulp therapies. In summary, four years ago, VCU was doing mostly ferric sulfate 
pulpotomies, and today over 90% of vital pulp therapy is indirect pulp therapy (See Table 4 and 
Figure 2).  
 Similar trends are demonstrated at other institutions. Dunston reported that in 2005, 83% 
of programs taught or used the indirect pulp therapy technique and Walker reported in 2013 that 
18% of program directors completely eliminated formocresol from the curriculum.5, 6 In 2009, 
Chaollai et al examined what was being taught in the United Kingdom and Ireland, it was found 
that 10/14 schools taught indirect pulp therapy and the most commonly used medicament was 
calcium hydroxide. All 14 schools taught the pulpotomy and the most popular medicament 
(13/14) was ferric sulfate, followed by formocresol (3/14). Interestingly, several schools reported 
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that they taught different techniques to undergraduate dental students versus residents.12 The 
article did not specify which techniques were taught to which level. 
Explanations for these trends can be mostly attributed to where and when faculty trained. 
Ferric sulfate was popular in the 1990’s and 2000’s as a safe alternative to the formocresol 
pulpotomy. During the 2000’s, faculty members who received their training in pediatric dentistry 
at VCU preferred the ferric sulfate pulpotomy. In 2010, many ferric sulfate pulpotomies were 
completed. However, with emerging research especially studies with 2 to 3 year follow up, the 
ferric sulfate pulpotomy was found to cause internal resorption, pulp canal obliteration, and 
subsequent failures.13 Many faculty went back to the formocresol pulpotomy in 2011. Also in 
2011, a new faculty member joined the staff from the University of Maryland, where indirect 
pulp therapy was taught to be the preferred method for vital pulp therapy over the pulpotomy 
treatment. Dr. Coll, who has reported favorable outcomes with indirect pulp therapy, was one of 
her mentors. Therefore, in 2011, VCU was also doing many indirect pulp therapies. In 2011, 
53% of vital pulp therapies were indirect pulp therapy, while 15% were ferric sulfate 
pulpotomies, and 28% were formocresol pulpotomies. After 2011, VCU was doing more indirect 
pulp therapy and less pulpotomy therapy. By 2014, 91% of vital pulp therapy was indirect pulp 
therapy (See Table 5 and Figure 2).  
Although many of VCU’s full time faculty prefers the indirect pulp therapy, many of the 
adjunct or part time faculty who also work in private practice, prefer the formocresol or ferric 
sulfate pulpotomy over indirect pulp therapy. Some of the part time faculty reported that they 
tried ferric sulfate in the past but due to failures ended up reverting back to formocresol. 
Additionally, part time faculty have stated that formocresol has worked relatively well for them; 
they do not see a need to change their technique. Another part time faculty member said he was 
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“not comfortable with indirect pulp therapy because he did not like leaving caries in the tooth”. 
Traditionally, dentists are taught in dental school to remove decay, therefore many practitioners 
feel that leaving decay is a disservice to the patient. Other adjunct faculty have mentioned that 
they do not get reimbursed for the indirect pulp therapy, and therefore do not do them. Perhaps if 
insurance companies reimbursed for indirect pulp therapy, it would be utilized more often. 
Formocresol use has been controversial over the past few decades, some regarding 
formaldehyde as a carcinogen causing leukemia and nasopharyngeal cancer.14 While others 
argue that formaldehyde is ubiquitous in our daily lives and if the formocresol pulpotomy is done 
correctly with a squeezed cotton pellet, the estimated amount of formaldehyde is 0.02 to 0.1mg, 
a minimal amount compared to a child’s natural daily exposure.15 Zarazar suggests that doing 
one formocresol pulpotomy on a child does not exhibit statistically significant mutagenic activity 
but more research needs to be done in scenarios where several formocresol pulpotomies are 
completed on one individual.16  
Seale found that 18% of pediatric dentists agree that formocresol being a carcinogen 
contraindicates its use, but 78% feel that it will eventually no longer be used not because of its 
danger to patients but due to the controversy surrounding its use. When asked “if cost were not 
an issue which is the recommended medicament for pulpotomy in the primary teeth”, MTA was 
the overwhelming winner.17 In a 2008 meta-analysis several articles reviewed show MTA’s 
clinical and radiographic success ranges from 93% to 100%.1 Unfortunately, due to MTA’s 
current high cost many residency programs including VCU do not use MTA for the primary 
tooth pulpotomy.  
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Table 5 and Figure 3 show that indirect pulp therapy remains successful (96.2%) over a 
three year time span, whereas, ferric sulfate and formocresol therapies are successful initially, 
there success wanes after three years. Survival analysis indicates a 65.8% survival after three 
years with formocresol and 62.9 % survival with ferric sulfate after three years. This difference 
is clinically significant P<.0001. The results are similar to other studies. Vij et al showed a 94% 
success rate at 40 months for indirect pulp therapy using glass ionomer and a 70% success rate 
for formocresol pulpotomies.18 Farooq et al showed 93 % success after 4.2 years using glass 
ionomer for indirect pulp therapy. While formocresol had a 74% success rate after 3.9 years.19 
Casas et al found that 33% of teeth treated using ferric sulfate pulpotomy should be extracted 
immediately at 3 year follow up.13 This is similar to the 62.9% three year survival rate for ferric 
sulfate pulpotomies that was found in this study. 
Landau and Johnsen (1988) used ferric sulfate, a hemostatic agent, to control pulpal 
hemorrhage before applying calcium hydroxide to pulptomized monkey teeth.20 The authors 
thought that controlling pulpal hemorrhage with ferric sulfate may prevent the problems 
previously encountered by blood clot formation with calcium hydroxide.7,21 In contact with 
blood, a ferric ion protein complex is formed and the membrane of this complex seals the cut 
blood vessels mechanically, producing hemostasis.20 Early short term studies showed ferric 
sulfate pulpotomy success.20 Fei et al reported 100% clinical success at 12 months. However, 
long term studies are less optimistic.13 Casas reported a probability of survival for FS molars at 
36 months was 0.62, which is similar to the three year results of this study.13 Ferric sulfate 
failures were attributed to internal and external resorption and pulp canal obliteration.13,22 
Resorption is thought to be caused by an inflammatory response, the very cause ferric sulfate 
was meant to prevent.  
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Perhaps it is not the ferric sulfate that caused the failures but the base material placed 
afterwards. Garcia-Godoy have found that ZOE is irritating to the pulp.20 IRM contains ZOE. In 
this study, the base material was not considered. However, in a formocresol pulpotomy, when the 
pulp tissue is fixed, the pulp would be unaffected by a base that was not inert, like ZOE, whereas 
in the ferric sulfate pulpotomy, the tissue is not fixed and the base is in direct contact with the 
pulp.20 It would be worthwhile to investigate the type of base that was used in the instances of 
ferric sulfate pulpotomy failure.  
Ranly suggests an increase in formocresol pulpotomy failure rates because the pulp is not 
given the chance to completely mummify in the one appointment formocresol pulpotomy. 
Historically, formocresol pulpotomies were completed in multiple visits so that the entire pulp 
was completely mummified. Multi-visit pulpotomies were very successful.7 According to Ranly 
doing the formocresol pulpotomy in one visit leaves the pulp in a half vital, half necrotic and 
chronically inflamed state, which in turn makes the tooth prone to failure. Also not leaving the 
formocresol pellet in the tooth for the recommended 5 minutes 2, 23, 24 may also lead to treatment 
failure. 
It is important to obtain hemostasis prior to application of the formocresol pellet. 
Practitioners may be tempted to rely on the formocresol or any other medicament for that matter, 
to obtain hemostasis. However, pulp tissue that is bleeding uncontrollably without medicament is 
probably irreversibly inflamed. Additional treatment, such as a pulpectomy or extraction, is 
likely indicated.25  
Once the infected layer of carious dentin is removed, the affected layer is treated with a 
biocompatible material such as glass ionomer. It is thought that indirect pulp therapy with glass 
ionomer is successful because of the antimicrobial effect of fluoride on mutans streptococci. The 
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bacteria are deprived of nutrients18 and thus the bacterial load decreases with a shift toward less 
cariogenic microflora. 26 Also glass ionomer has the effect of drying out of the moist soft 
leathery decay, 18 the pulp is sealed and able to recover. Calcium hydroxide is traditionally the 
material of choice in deep carious treatment because of its alkaline biocompatible properties and 
the induction of tertiary dentin. However, resin modified glass ionomer (RMGI)  has been found 
to have comparable success rates to calcium hydroxide but unlike calcium hydroxide RMGI is 
better at preventing microleakage. 26  
Franzon and Marchi propose that re-hardening of dentin occurs independently of the use 
and type of capping material so long as there is an adequate seal. Mineral gain is the biological 
response of the pulp. 27,28 Furthermore, Opal and Massler agree that the pulp’s reaction to dental 
caries is productive not degenerative and sclerosis of the underlying dentin and reparative dentin 
is the rule not the exception.29 However, the capping material does provide an important seal so 
that the pulp can heal. The capping material creates an undesirable, nutrient poor, 
microenvironment for the trapped bacteria.29,30 Opal proposes that the benefit of materials such 
as calcium hydroxide and glass ionomer is that the initial low pH setting has a superficial 
solubilizing effect on dentin immediately after placement. As a result bioactive molecules such 
as transforming growth factor could induce odontoblasts to produce intratubular and reactionary 
dentin in order to decrease dentin permeability and provide a barrier against invading   
bacteria.29, 30  
         In addition to having an adequate seal with a biocompatible material, case selection or 
proper diagnosis is also very important.29, 31Any vital pulp therapy can fail because of incorrect 
pulpal diagnosis. Waterhouse suggests that there may be an exception with the formocresol 
pulpotomy; with a 5 minute application of 20% dilution of Buckley’s formocresol, even a non-
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vital pulp has a good prognosis due to the devitalizing nature of formocresol3 suggesting that 
diagnosis is not as important when using formocresol. In this study, 50% of the indirect pulp 
therapies that failed, did so within the first year (Table 5). Perhaps these teeth were instances of 
pulpal misdiagnosis or perhaps the diagnosis was unclear. Sometimes the pulpal diagnosis is not 
obvious, in which case Coll suggests a pretreatment glass ionomer temporary restoration for one 
to three months. Not only does the glass ionomer temporary restoration inhibit caries 
progression, it can also aid in pulpal diagnosis. Teeth pretreated with glass ionomer were more 
accurately diagnosed with correct pulpal diagnosis then when pretreatment temporary 
restorations were not completed. 31 The interim restoration allows time for the pulp to form a 
fistula or some obvious radiographic lesion indicating the pulp is irreversibly involved. 31 If the 
pulp is not irreversibly inflamed then the temporary restoration can be removed and vital pulp 
therapy can be initiated. The pretreatment temporary restorations also improved the success of 
vital pulp therapy procedures especially on teeth with proximal lesions.31  
 It is important to consider all diagnostic tools when determining pulpal status. 
Radiographs, symptoms, and clinical presentation ought to be reviewed.9 However, even after 
careful review of diagnostic aids, the correlation between histologic findings and clinical 
symptoms is poor.26,32 Gruythuysen contends that once dentin has been affected pulpal 
inflammation is inevitable. Subjacent to deep caries, the pulp has chronic inflammatory exudates 
(lymphocytes, macrophages, plasma cells) indicating that pulpitis has developed even in the 
absence of pain.26 Fortunately, the young, vascular primary tooth withstands this inflammation 
and has the capacity to heal. Histologically inflamed teeth can survive for extended periods of 
time.33 Perhaps, the inflamed coronal pulp should not necessarily be considered a forerunner to 
necrosis or irreversible inflammation, but a state of potential regeneration and repair.26 
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 If marginal breakdown is present, Coll and Kassa suggest that pulp inflammation is 
usually extensive, and perhaps vital pulp therapy should not be considered.31,34 Moreover, in 
Gopinath’s study, primary second molars with more than 2/3 caries involvement and symptoms 
of pain, histologically showed inflammation of both coronal and radicular pulp tissues. 
Consequently, pulpectomies were treatment planned. 35 
In general, in the United States, indirect pulp therapy has been carried out in one step. 
One step is more cost effective, less time consuming, and could potentially be less traumatic to 
the patient especially if behavior is less than optimal. However, Scandinavian countries 
traditionally utilize a stepwise excavation approach, 36 where the caries is removed in two 
separate appointments placing RMGI or calcium hydroxide or both after the first appointment. 
Both techniques have their advantages, however, Orhan found that there was no significant 
difference between one and two visit indirect pulp therapy in terms of pulp exposure and success 
rate.37 At VCU the one step approaching is typically taken, where the indirect pulp therapy and 
crown are placed in the same appointment. However, recently, for many of our patients who 
have to wait until an operating room is available, sedative fillings are temporarily placed. 
Typically, a glass ionomer or a RMGI is placed after minimally invasive caries excavation. 
Therefore, a modified version of the stepwise approach is utilized for our patients that are 
waiting to go to the operating room. As mentioned previously this pretreatment temporary can 
also be useful in pulpal diagnosis if the inflammatory status of the pulp is not clear.   
In this study there was no difference in success rate for any pulp therapy procedure in 
primary first or second molars (See Figure 4). There were roughly equal number of failures in 
primary first and second molars. Another study found first primary molars treated with indirect 
pulp therapy  were significantly more likely to fail than second primary molars.38 Vij et al 
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showed that primary first molars had a combined indirect pulp therapy or formocresol success 
rate of 76%, which was lower than the indirect pulp therapy or formocresol success rate of 91% 
in the primary second molars.18  There was no explanation provided in this article, however in 
another article by Coll it is suggested that primary first molars demonstrate more interproximal 
caries.31 Teeth with deep interproximal caries, as opposed to deep occlusal caries, generally have 
more pulpal inflammation, and subsequently fail more often. Therefore, vital pulp therapy 
procedures completed on primary first molars are more likely to fail because they tend to have 
more proximal caries and pulpal inflammation.31 
 A major limitation to the study was that some of the patients who underwent treatment 
did not return for follow up, so it is not known whether treatments (indirect pulp therapy or 
pulpotomy) failed or survived. As time progressed, there was less data available because of 
patient compliance and therefore, the confidence interval is broad (0-100) (Table 5). Future 
studies should follow teeth that have had regular recall visits for long term follow up.   
 Another limitation was a large variation in caries depth for some of the teeth treated with 
indirect pulp therapies. Some teeth had decay approaching the pulp while other teeth had 
minimal decay. A tooth with minimal caries is going to have a high chance of remaining vital 
even without an indirect pulp therapy procedure. There is growing consensus that the residual 
dentin thickness (the depth of unaffected hard tissue between the base of the caries lesion and the 
pulp periphery) may be the most predictive measure of likely pulpal reactions. 29, 31, 34 In this 
study, proximal lesions were also not differentiated from occlusal lesions. It has been suggested 
that proximal lesions in conjunction with caries that extend beyond 50% of dentin thickness 
show severe inflammatory changes.34 Opal contends that 0.25-0.50mm of sound dentin provides 
a safeguard for a speedy recovery of the dental pulp to health.29 Cavities placed closer to the pulp 
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appear to injure underlying odontoblasts, reducing their number and capacity to form reactionary 
dentin.29 A subsequent study is underway that will exclude teeth that had indirect pulp therapy 
with only minimal cares i.e. caries that is only 1/3 into dentin or less.   
 In this study only teeth that were extracted or had a pulpectomy were counted as a failure. 
However, there were teeth that came out prematurely that were not counted as a failure. There 
were teeth that were planned for extraction but since the patient did not return for the extraction 
appointment, that tooth was not considered a failure. There were radiographic failures that were 
not considered a failure. Conversely, there were some teeth that were extracted, and therefore 
considered a failure that some practitioners would consider a success. For example, a 
pulpotomized tooth that lasts several years and is extracted at the time of intended exfoliation 
may be considered a success. A few teeth were extracted because the tooth was about to exfoliate 
and root tips remained. In one scenario the crown fell off and the remaining tooth was extracted 
and therefore considered a failure.  
 The vast majority of teeth were restored with a stainless steel crown (SSC), especially 
those that were treated with pulpotomies. There were a small number of indirect pulp therapy 
teeth that were restored with resin composite. In general teeth that were not restored with a 
crown also had minimal caries into dentin. In future studies, teeth with minimal caries should be 
excluded, however, several sources state that the type of restoration (SSC or composite) does not 
matter so long as there is an adequate seal.9,18  Vital pulp therapy procedures restored with poorly 
sealed restorations that allow bacterial invasion will fail.  
 The results of this study indicate that indirect pulp therapy is a successful treatment 
option for the reversibly inflamed tooth. The department is justified in using it with frequency. 
Primary and young immature permanent teeth have the remarkable ability to heal without much 
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human intervention.39 Perhaps practitioners underestimate the pulps’ ability to heal, and should 
utilize a more conservative approach. Hume humorously stated that dentists should modify their 
200 year old philosophy that caries should be treated like gangrene by extracting or excavating 
and filling.29 More aggressive treatment options should not be discredited, the pulpotomy 
certainly has its place, a pulp exposure would certainly justify the pulpotomy procedure. 
However, clinicians should consider MTA or perhaps the formocresol pulpotomy if the tooth 
needs to last for several years. Ferric sulfate pulpotomies could be used successfully in the short 
term. Perhaps with this and other studies that show indirect pulpotomy success, other residency 
programs and eventually practitioners will utilize indirect pulp therapy more frequently.   
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Conclusions 
 
 
 The purpose of this retrospective study was to identify how reversible pulpitis in the 
primary posterior tooth has been treated over the past four years at VCU pediatric dentistry, and 
also to determine which treatments modalities (indirect pulp therapy, formocresol pulpotomy, or 
ferric sulfate pulpotomy) have been successful. The following conclusions can be made from this 
study: 
1.  In 2010, 52% of vital pulp therapies were ferric sulfate pulpotomies. In 2013 and 
2014 over 90% of vital pulp therapies were indirect pulp therapy. Formocresol 
pulpotomy saw most use in 2011 at 28%.  
2. Indirect pulp therapy had a 96.2% success rate, while the formocresol pulpotomy had 
a 65.8% success rate and ferric sulfate had a 62.9% success rate at three years. This 
difference was significant P < .0001. 
Considering the results, it has been concluded that the trend towards favoring indirect pulp 
therapy for primary posterior teeth needing vital pulp therapy is justified and that the vital pulp 
therapy curriculum at VCU pediatric dentistry does not need to be modified at this time. 
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Table 1. Demographic Characteristics of Patients (N=907) 
Characteristic N % 
Sex   
Female 410 45.2 
Male 497 54.8 
Race/Ethnicity* 
African-
American 236 47.9 
Asian 8 1.6 
Caucasian 181 36.7 
Hispanic 56 11.4 
Other 12 2.4 
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Table 2. Teeth Treated in the Study 
Tooth N % 
A 233 11.2 
B 205 9.9 
I 220 10.6 
J 260 12.5 
K 312 15.1 
L 285 13.8 
S 262 12.6 
T 295 14.2 
Total: 2,072 teeth 
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Table 3. Number of Patients by Year (N=907) 
Year N % 
2010 107 11.8 
2011 229 25.2 
2012 192 21.2 
2013 273 30.1 
2014 106 11.7 
Note that the AxiUm database began in July, 2010 and that patients seen through May 2014 were 
included in the study. 
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Table 4. Number of Procedures by Year 
 
Pulp Therapy - Indirect 
Therapeutic Pulpotomy 
Year Formocresol Ferric sulfate Other*
2010 88 (38%) 11 (5%) 120 (52%) 10 (4%)
2011 253 (54%) 131 (28%) 72 (15%) 12 (3%)
2012 387 (83%) 64 (14%) 8 (2%) 7 (2%)
2013 603 (91%) 28 (4%) 2 (0%) 29 (4%)
2014 224 (91%) 4 (2%) 6 (2%) 13 (5%)
Total 1555 (75%) 238 (11%) 208 (10%) 71 (3%)
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Table 5. Kaplan-Meier Survival Analysis Results 
 
Time 
(years) 
Survival 
(%) 
  Number 
Treatment 95% CI Failures Censored
At 
risk 
D3120 0 100.0   0 713 1555 
D3220FC 0 100.0   0 106 238 
D3220FS 0 100.0   0 76 208 
D3120 1 99.3 97.8 100 3 558 281 
D3220FC 1 98.9 96.9 100 1 78 54 
D3220FS 1 87.2 62.1 100 11 128 70 
D3120 2 98.8 96.3 100 1 173 105 
D3220FC 2 85.9 58.3 100 5 21 28 
D3220FS 2 75.6 27.8 100 8 12 50 
D3120 3 96.2 88.7 100 2 68 34 
D3220FC 3 65.8 0.0 100 3 21 4 
D3220FS 3 62.9 0.0 100 7 20 26 
* Groups significantly different by the log-rank test (df = 2, chi-square = 58.1, P < .0001) 
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Figure 1. Age Distribution of Patients 
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Figure 2. Percentage of Procedures by Year 
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Figure 3. Kaplan-Meier Survival Analysis Results 
 
* Groups significantly different by the log-rank test (df=2, chi-square=58.1, P < .0001) 
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Figure 4. Kaplan-Meier Survival Analysis by Tooth type 
 
*Groups were not significantly different (P>0.6)
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